Hartmann A - Search Results

1

Parkin immunoreactivity in the brain of human and non-human primates: an immunohistochemical analysis in normal conditions and in Parkinsonian syndromes.

Zarate-Lagunes M, Gu WJ, Blanchard V, Francois C, Muriel MP, Mouatt-Prigent A, Bonici B, Parent A, Hartmann A, Yelnik J, Boehme GA, Pradier L, Moussaoui S, Faucheux B, Raisman-Vozari R, Agid Y, Brice A, Hirsch EC. Zarate-Lagunes M, et al. Among authors: hartmann a. J Comp Neurol. 2001 Apr 2;432(2):184-96. doi: 10.1002/cne.1096. J Comp Neurol. 2001. PMID: 11241385

2

CD95 (APO-1/Fas) and Parkinson's disease.

Hartmann A, Hunot S, Hirsch EC. Hartmann A, et al. Ann Neurol. 1998 Sep;44(3):425-6. doi: 10.1002/ana.410440330. Ann Neurol. 1998. PMID: 9749619 No abstract available.

3

FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.

Hunot S, Dugas N, Faucheux B, Hartmann A, Tardieu M, Debré P, Agid Y, Dugas B, Hirsch EC. Hunot S, et al. Among authors: hartmann a. J Neurosci. 1999 May 1;19(9):3440-7. doi: 10.1523/JNEUROSCI.19-09-03440.1999. J Neurosci. 1999. PMID: 10212304 Free PMC article.

4

Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.

Hartmann A, Hunot S, Michel PP, Muriel MP, Vyas S, Faucheux BA, Mouatt-Prigent A, Turmel H, Srinivasan A, Ruberg M, Evan GI, Agid Y, Hirsch EC. Hartmann A, et al. Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2875-80. doi: 10.1073/pnas.040556597. Proc Natl Acad Sci U S A. 2000. PMID: 10688892 Free PMC article.

5

Mechanism of cell death in experimental models of Parkinson's disease.

Hirsch EC, Hunot S, Hartmann A. Hirsch EC, et al. Among authors: hartmann a. Funct Neurol. 2000 Oct-Dec;15(4):229-37. Funct Neurol. 2000. PMID: 11213526 No abstract available.

6

Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?

Hartmann A, Michel PP, Troadec JD, Mouatt-Prigent A, Faucheux BA, Ruberg M, Agid Y, Hirsch EC. Hartmann A, et al. J Neurochem. 2001 Mar;76(6):1785-93. doi: 10.1046/j.1471-4159.2001.00160.x. J Neurochem. 2001. PMID: 11259496 Free article.

7

Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis.

Hartmann A, Troadec JD, Hunot S, Kikly K, Faucheux BA, Mouatt-Prigent A, Ruberg M, Agid Y, Hirsch EC. Hartmann A, et al. J Neurosci. 2001 Apr 1;21(7):2247-55. doi: 10.1523/JNEUROSCI.21-07-02247.2001. J Neurosci. 2001. PMID: 11264300 Free PMC article.

8

Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.

Turmel H, Hartmann A, Parain K, Douhou A, Srinivasan A, Agid Y, Hirsch EC. Turmel H, et al. Among authors: hartmann a. Mov Disord. 2001 Mar;16(2):185-9. doi: 10.1002/mds.1037. Mov Disord. 2001. PMID: 11295768

9

Parkinson's disease. The apoptosis hypothesis revisited.

Hartmann A, Hirsch EC. Hartmann A, et al. Adv Neurol. 2001;86:143-53. Adv Neurol. 2001. PMID: 11553972 Review. No abstract available.

10

FADD: A link between TNF family receptors and caspases in Parkinson's disease.

Hartmann A, Mouatt-Prigent A, Faucheux BA, Agid Y, Hirsch EC. Hartmann A, et al. Neurology. 2002 Jan 22;58(2):308-10. doi: 10.1212/wnl.58.2.308. Neurology. 2002. PMID: 11805265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,391 results

Search Page